Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4

Laboratory Investigation

Volumn 94, Issue 9, 2014, Pages 1042-1053

  Chu, Heling ^a   Ding, Hongyan ^a   Tang, Yuping ^a   Dong, Qiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; ERYTHROPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; OCCLUDIN; PROTEIN ZO1; RECOMBINANT ERYTHROPOIETIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE CULTURE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMORRHAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; MEMBRANE PERMEABILITY; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; AQUAPORIN 4; ASTROCYTES; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELLS, CULTURED; ERYTHROPOIETIN; FLUORESCENT ANTIBODY TECHNIQUE; MALE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

EID: 84906832995     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.84     Document Type: Article

References (37)

1. Wang Y, Zhang ZG, Rhodes K, et al. Post-ischemic treatment witherythropoietin or carbamylated erythropoietin reduces infarction andimproves neurological outcome in a rat model of focal cerebralischemia. Br J Pharmacol 2007;151:1377-1384.
2. Li Y, Lu Z, Keogh CL, et al. Erythropoietin-induced neurovascularprotection, angiogenesis, and cerebral blood flow restoration afterfocal ischemia in mice. J Cerebr Blood F Met 2007;27:1043-1054.
3. Lee ST, Chu K, Sinn DI, et al. Erythropoietin reduces perihematomalinflammation and cell death with eNOS and STAT3 activations inexperimental intracerebral hemorrhage. J Neurochem 2006;96:1728-1739.
4. Seyfried DM, Han Y, Yang D, et al. Erythropoietin promotesneurological recovery after intracerebral haemorrhage in rats. Int JStroke 2009;4:250-256.
5. Chi OZ, Hunter C, Liu X, et al. Effects of erythropoietin on blood-brainbarrier disruption in focal cerebral ischemia. Pharmacology2008;82: 38-42.
6. Liu K, Sun T, Wang P, et al. Effect s of erythropoietin on blood-brainbarrier tight junctions in ischemia-reperfusion rats. J Mol Neurosci2013;49:369-379.
7. Li Y, Ogle ME, Wallace IV GC, et al. Erythropoietin attenuatesintracerebral hemorrhage by diminishing matrix metalloproteinasesand maintaining blood-brain barrier integrity in mice. Acta NeurochirSuppl 2008;105:105-112.
8. Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema.Pediatr Nephrol 2007;22:778-784.
9. Nico B, Frigeri A, Nicchia GP, et al. Role of aquaporin-4 water channelin the development and integrity of the blood-brain barrier. J Cell Sci2001;114:1297-1307.
10. Zhou JP, Kong H, Hua XD, et al. Altered blood-brain barrier integrity inadult aquaporin-4 knockout mice. Neuroreport 2008;191-5.
11. Tang Y, Wu P, Su J, et al. Effects of aquaporin-4 on edema formationfollowing intracerebral hemorrhage. Exp Neurol 2010;223:485-495.
12. Brissaud O, Villega F, Konsman JP, et al. Short-term effect oferythropoietin on brain lesions and aquaporin-4 expression in ahypoxic-ischemic neonatal rat model assessed by magnetic resonancediffusion weighted imaging and immunohistochemistry. Pediatr Res2010;68:123-127.
13. Tang Z, Sun X, Huo G, et al. Protective effects of erythropoietin onastrocytic swelling after oxygeneglucose deprivation andreoxygenation: Mediation through AQP4 expression and MAPKpathway. Neuropharmacology 2013;67:8-15.
14. Cotena S, Piazza O, Tufano R. The use of erythropoietin in cerebraldiseases. Panminerva Med 2008;50:185-192.
15. Sirén AL, Fabhauer T, Bartels C, et al. Therapeutic potential oferythropoietin and its structural or functional variants in the nervoussystem. Neurotherapeutics 2009;6:108-127.
16. Rao KVR, Jayakumar AR, Reddy PVB, et al. Aquaporin-4 in manganesetreatedcultured astrocytes. Glia 2010;58:1490-1499.
17. Yang M, Gao F, Liu H, et al. Hyperosmotic induction of aquaporinexpression in rat astrocytes through a different MAPK pathway. J CellBiochem 2013;114:111-119.
18. Yang CS, Tzou BC, Liu YP, et al. Inhibition of cadmium-inducedoxidative injury in rat primary astrocytes by the addition ofantioxidants and the reduction of intracellular calcium. J CellBiochem 2008;183:213-221.
19. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuatescytokine production and inflammation in cerebral ischemia bytargeting neuronal apoptosis. J Exp Med 2003;198:971-975.
20. Kawasaki T, Kitao T, Nakagawa K, et al. Nitric oxide-induced apoptosisin cultured rat astrocytes: Protection by edaravone, a radicalscavenger. Glia 2007;55:1325-1333.
21. Sinke AP, Jayakumar AR, Panickar KS, et al. NFkB in the mechanism ofammonia-induced astrocyte swelling in culture. J Neurochem2008;106:2302-2311.
22. Habas A, Kharebava G, Szatmari E, et al. NMDA neuroprotectionagainst a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2Bmediatedsuppression of glycogen synthase kinase-3b-inducedapoptosis. J Neurochem 2006;96:335-348.
23. Vitellaro-Zuccarello L, Mazzetti S, Madaschi L, et al. Chronicerythropoietin-mediated effects on the expression of astrocytemarkers in a rat model of contusive spinal cord injury. Neuroscience2008;151:452-466.
24. Hasselblatt M, Ehrenreich H, Sirén AL. The brain erythropoietin systemand its potential for therapeutic exploitation in brain disease.J Neurosurg Anesthesiol 2006;18:132-138.
25. Hellewell SC, Yan EB, Alwis DS, et al. Erythropoietin improves motorand cognitive deficit, axonal pathology, and neuroinflammation in acombined model of diffuse traumatic brain injury and hypoxia, inassociation with upregulation of the erythropoietin receptor.J Neuroinflamm 2013;10:156-176.
26. Grasso G, Graziano F, Sfacteria A, et al. Neuroprotective effect oferythropoietin and darbepoetin alfa after experimental intracerebralhemorrhage. Neurosurgery 2009;65:763-770.
27. Li Y, Lu ZY, Ogle M, et al. Erythropoietin prevents blood brain barrierdamage induced by focal cerebral ischemia in mice. Neurochem Res2007;32:2132-2141.
28. Haj-Yasein NN, Vindedal GF, Eilert-Olsen M, et al. Glial- conditionaldeletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake andconfers barrier function on perivascular astrocyte endfeet. Proc NatlAcad Sci USA 2011;108:17815-17820.
29. Eilert-Olsen M, Haj-Yasein NN, Vindedal GF, et al. Deletion ofaquaporin-4 changes the perivascular glial protein scaffold withoutdisrupting the brain endothelial barrier. Glia 2012;60:432-440.
30. Kimura A, Hsu M, Seldin M, et al. Protective role of aquaporin-4 waterchannels after contusion spinal cord Injury. Ann Neurol 2010;67:794-801.
31. Tait MJ, Saadoun S, Bell BA, et al. Increased brain edema in AQP4-nullmice in an experiment model of subarachnoid hemorrhage.Neuroscience 2010;167:60-67.
32. Chu H, Tang Y, Dong Q. Protection of vascular endothelial growthfactor to brain edema following intracerebral hemorrhage and itsinvolved mechanisms: Effect of aquaporin-4. Plos One 2013;8:e66051-e66064.
33. Chu H, Tang Y, Dong Q. Protection of granulocyte-colony stimulatingfactor to hemorrhagic brain injuries and its involved mechanisms:effects of vascular endothelial growth factor and aquaporin-4.Neuroscience 2014;260:59-72.
34. Bose C, Udupa KB. Erythropoietin enhancement of rat pancreatictumor cell proliferation requires the activation of ERK and JNK signals.Am J Physiol Cell Physiol 2008;295:C394-C405.
35. Burger D, Xiang F, Hammoud L, et al. Role of heme oxygenase-1in the cardioprotective effects of erythropoietin during myocardialischemia and reperfusion. Am J Physiol Heart Circ Physiol 2009;296:H84-H93.
36. Ben-Ari Z, Zilbermints V, Pappo O, et al. Erythropoietin increasessurvival and attenuates fulminant hepatic failure injury induced byD-galactosamine/lipopolysaccharide in mice. Transplantation 2011;92:18-24.
37. Li Y, Chen G, Zhao J, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)induces microglial nitric oxide production and subsequent rat primarycortical neuron apoptosis through p38/JNK MAPK pathway.Toxicology 2013;312:132-141.